Header Logo

Marc Fisher

Concepts (206)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
43
2020
1127
6.570
Why?
Brain Ischemia
32
2019
399
5.880
Why?
Neuroprotective Agents
10
2016
72
2.030
Why?
Tissue Plasminogen Activator
8
2016
125
2.000
Why?
Cerebrovascular Circulation
13
2012
174
1.700
Why?
Infarction, Middle Cerebral Artery
7
2009
70
1.630
Why?
Clinical Trials as Topic
15
2016
441
1.620
Why?
Periodicals as Topic
4
2017
166
1.420
Why?
Diffusion Magnetic Resonance Imaging
11
2009
145
1.400
Why?
Thrombectomy
3
2019
208
1.240
Why?
Endovascular Procedures
4
2019
608
1.120
Why?
Fibrinolytic Agents
5
2010
163
1.100
Why?
Editorial Policies
2
2017
52
1.000
Why?
Thrombolytic Therapy
7
2016
184
0.990
Why?
Reperfusion Injury
4
2016
49
0.890
Why?
Platelet Aggregation Inhibitors
4
2009
211
0.890
Why?
Disease Models, Animal
14
2013
2046
0.880
Why?
Ischemic Attack, Transient
4
2018
90
0.780
Why?
Rats
17
2013
1909
0.720
Why?
Time Factors
16
2019
3614
0.660
Why?
Reperfusion
5
2010
35
0.660
Why?
Magnetic Resonance Imaging
7
2009
2059
0.640
Why?
Drug Design
3
2010
137
0.620
Why?
Treatment Outcome
13
2020
5283
0.590
Why?
Decision Support Techniques
1
2019
179
0.570
Why?
Animals
31
2016
19601
0.570
Why?
Anticoagulants
5
2020
477
0.560
Why?
Brain
7
2007
1487
0.540
Why?
Magnetic Resonance Angiography
3
2006
178
0.500
Why?
Humans
43
2020
59282
0.490
Why?
Warfarin
3
2020
105
0.490
Why?
Health Planning Guidelines
2
2007
31
0.490
Why?
Rats, Sprague-Dawley
11
2008
574
0.470
Why?
Ticlopidine
2
2006
45
0.470
Why?
Granulocyte Colony-Stimulating Factor
2
2013
39
0.430
Why?
Acute Disease
8
2010
659
0.390
Why?
Freezing
1
2011
18
0.380
Why?
Recovery of Function
4
2019
270
0.370
Why?
Embolism
2
2008
39
0.360
Why?
Thrombophilia
1
2010
14
0.350
Why?
Brain Injuries
2
2013
135
0.350
Why?
Aspirin
2
2009
166
0.340
Why?
Intracellular Signaling Peptides and Proteins
1
2011
324
0.320
Why?
Cerebral Infarction
2
2007
76
0.320
Why?
Male
22
2019
27727
0.320
Why?
Research
2
2009
188
0.310
Why?
Laser-Doppler Flowmetry
1
2008
6
0.310
Why?
Intracranial Embolism
1
2009
39
0.310
Why?
Brain Infarction
1
2008
19
0.310
Why?
Gadolinium
1
2009
103
0.310
Why?
Hyperoxia
1
2008
16
0.310
Why?
Behavior, Animal
2
2007
215
0.310
Why?
Biomedical Technology
1
2007
6
0.280
Why?
Contrast Media
1
2009
408
0.270
Why?
Atrial Fibrillation
3
2020
805
0.270
Why?
Cerebral Arteries
1
2007
39
0.270
Why?
Rats, Wistar
4
2013
179
0.270
Why?
Middle Cerebral Artery
1
2006
46
0.250
Why?
Membrane Proteins
1
2011
846
0.250
Why?
Dimethyl Sulfoxide
1
2005
17
0.250
Why?
Drug Evaluation, Preclinical
1
2005
89
0.240
Why?
Device Approval
1
2005
13
0.240
Why?
Telemedicine
2
2009
307
0.230
Why?
Diffusion
5
2008
82
0.220
Why?
Cerebral Cortex
1
2005
248
0.220
Why?
Research Design
2
2005
555
0.220
Why?
Recombinant Proteins
3
2016
688
0.210
Why?
Patient Selection
3
2016
464
0.210
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2005
206
0.210
Why?
Stem Cell Transplantation
1
2003
75
0.210
Why?
Factor Xa Inhibitors
2
2020
34
0.200
Why?
Heparin, Low-Molecular-Weight
1
2002
26
0.200
Why?
Neurons
2
2011
863
0.190
Why?
Blood Pressure
3
2010
495
0.190
Why?
Heparin
1
2002
111
0.190
Why?
Neuroimaging
2
2013
143
0.190
Why?
Disease Management
1
2003
221
0.180
Why?
Astrocytes
1
2002
116
0.180
Why?
Aged, 80 and over
5
2020
5128
0.180
Why?
Injections, Intravenous
3
2006
155
0.180
Why?
Drug Therapy, Combination
3
2009
452
0.180
Why?
Risk Factors
4
2019
4982
0.170
Why?
China
1
2019
134
0.160
Why?
Rivaroxaban
1
2018
19
0.150
Why?
Dabigatran
1
2018
20
0.150
Why?
Tomography, X-Ray Computed
1
2006
1525
0.150
Why?
Disability Evaluation
1
2019
199
0.150
Why?
Risk Assessment
2
2019
1920
0.150
Why?
Regional Blood Flow
2
2008
108
0.140
Why?
Aged
6
2020
13412
0.140
Why?
Homes for the Aged
1
2019
157
0.140
Why?
Hemorrhage
3
2019
260
0.140
Why?
Secondary Prevention
3
2018
151
0.130
Why?
Protein C
1
2016
29
0.130
Why?
Predictive Value of Tests
1
2019
1025
0.130
Why?
Nursing Homes
2
2020
661
0.130
Why?
Neurology
1
2016
33
0.130
Why?
Registries
1
2019
801
0.130
Why?
Health Services Needs and Demand
1
2017
203
0.130
Why?
Clinical Protocols
1
2016
135
0.120
Why?
Reproducibility of Results
1
2019
1561
0.120
Why?
Middle Aged
4
2019
16310
0.120
Why?
Randomized Controlled Trials as Topic
2
2009
677
0.110
Why?
Practice Patterns, Physicians'
1
2019
687
0.110
Why?
Retrospective Studies
3
2020
6071
0.110
Why?
Diagnostic Imaging
2
2008
243
0.110
Why?
Cerebral Hemorrhage
2
2005
85
0.100
Why?
United States
5
2020
7385
0.100
Why?
Language
1
2014
133
0.100
Why?
Health Services Accessibility
1
2017
521
0.100
Why?
Cognition Disorders
1
2013
215
0.100
Why?
Tetrazolium Salts
2
2008
15
0.100
Why?
Disks Large Homolog 4 Protein
1
2011
19
0.090
Why?
Factor V Deficiency
1
2010
1
0.090
Why?
Protein S Deficiency
1
2010
1
0.090
Why?
Protein C Deficiency
1
2010
2
0.090
Why?
Antithrombin III Deficiency
1
2010
2
0.090
Why?
Vascular Surgical Procedures
1
2013
251
0.090
Why?
Medicare
3
2020
598
0.090
Why?
Foramen Ovale, Patent
1
2010
13
0.090
Why?
Female
5
2019
30695
0.090
Why?
Cell Death
1
2011
271
0.080
Why?
Cortical Spreading Depression
1
2009
7
0.080
Why?
Hospital Units
1
2009
8
0.080
Why?
Cost-Benefit Analysis
1
2010
297
0.080
Why?
Health Care Sector
1
2009
20
0.080
Why?
Magnetic Field Therapy
1
2008
3
0.080
Why?
Infusions, Intra-Arterial
1
2008
12
0.080
Why?
Administration, Oral
2
2020
356
0.080
Why?
Functional Laterality
2
2006
133
0.080
Why?
Species Specificity
1
2009
328
0.070
Why?
Image Processing, Computer-Assisted
3
2007
653
0.070
Why?
Infusions, Intravenous
1
2008
164
0.070
Why?
Guidelines as Topic
1
2009
153
0.070
Why?
Blood Glucose
1
2010
461
0.070
Why?
Drug Administration Schedule
1
2008
283
0.070
Why?
Peptides
1
2011
547
0.070
Why?
Case-Control Studies
1
2010
1051
0.070
Why?
Injury Severity Score
1
2007
101
0.070
Why?
Equipment Design
1
2008
329
0.070
Why?
Virginia
1
2007
23
0.070
Why?
Radiography
2
2006
516
0.070
Why?
Cells, Cultured
1
2011
2089
0.070
Why?
Benzenesulfonates
1
2006
13
0.070
Why?
Electrocardiography
1
2009
523
0.060
Why?
Practice Guidelines as Topic
1
2010
705
0.060
Why?
Brain Mapping
1
2007
228
0.060
Why?
Rats, Inbred WKY
1
2005
11
0.060
Why?
Body Temperature
1
2005
45
0.060
Why?
Drug Industry
1
2005
39
0.060
Why?
Legislation, Drug
1
2005
17
0.060
Why?
Product Surveillance, Postmarketing
1
2005
20
0.060
Why?
Equipment Safety
1
2005
20
0.060
Why?
Carbon Dioxide
1
2005
81
0.060
Why?
Drug Approval
1
2005
25
0.060
Why?
Models, Animal
1
2005
221
0.060
Why?
Cerebrovascular Disorders
1
2005
74
0.060
Why?
Risk
1
2005
364
0.060
Why?
United States Food and Drug Administration
1
2005
85
0.060
Why?
Regression Analysis
1
2005
485
0.060
Why?
Aspirin, Dipyridamole Drug Combination
1
2003
3
0.060
Why?
Quality of Health Care
1
2008
510
0.060
Why?
Dipyridamole
1
2003
17
0.060
Why?
Heart Rate
1
2005
307
0.050
Why?
Software
1
2007
367
0.050
Why?
Hydrogen-Ion Concentration
1
2005
447
0.050
Why?
Pharmaceutical Preparations
1
2005
117
0.050
Why?
Thrombosis
1
2006
181
0.050
Why?
Cohort Studies
2
2020
2372
0.050
Why?
Drug Combinations
1
2003
146
0.050
Why?
Recurrence
1
2005
602
0.050
Why?
Oxygen
1
2005
313
0.050
Why?
Odds Ratio
1
2005
745
0.050
Why?
Multivariate Analysis
1
2005
902
0.050
Why?
Drug Synergism
1
2003
132
0.050
Why?
Treatment Failure
1
2003
185
0.050
Why?
Combined Modality Therapy
1
2003
355
0.050
Why?
Adult
2
2009
15663
0.050
Why?
Microscopy, Electron
1
2002
247
0.050
Why?
Disease Progression
1
2005
1122
0.040
Why?
Decision Making
1
2004
394
0.040
Why?
Water
1
2002
300
0.040
Why?
Severity of Illness Index
1
2005
1479
0.040
Why?
Follow-Up Studies
1
2005
2337
0.040
Why?
Prospective Studies
1
2007
3065
0.040
Why?
Drug Substitution
1
2019
40
0.040
Why?
Algorithms
1
2004
976
0.040
Why?
Thromboembolism
1
2018
69
0.040
Why?
Intracranial Hemorrhages
1
2018
61
0.040
Why?
Health Care Surveys
1
2019
271
0.040
Why?
Mice
1
2011
10251
0.040
Why?
Skilled Nursing Facilities
1
2018
83
0.040
Why?
Drug Utilization
1
2019
208
0.040
Why?
Urbanization
1
2017
2
0.040
Why?
Proportional Hazards Models
1
2018
674
0.030
Why?
Nursing Staff, Hospital
1
2017
65
0.030
Why?
Mechanical Thrombolysis
1
2016
35
0.030
Why?
Double-Blind Method
1
2016
715
0.030
Why?
Area Under Curve
1
2013
141
0.030
Why?
Cross-Sectional Studies
1
2019
2373
0.020
Why?
Myocardial Infarction
1
2018
862
0.020
Why?
Neuropsychological Tests
1
2013
371
0.020
Why?
Silicon
1
2006
19
0.020
Why?
Sutures
1
2006
35
0.020
Why?
Perfusion
1
2006
79
0.020
Why?
Surface Properties
1
2006
270
0.020
Why?
Fisher's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (206)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_